Kun Run Biotechnology, Inc. – Filings and Transcripts – BamSEC

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

SEC EDGAR

Financials Filter

ended 09/30/10 Q3

Late quarterly filing notification for Q3 2010

ended 06/30/10 Q2

Late quarterly filing notification for Q2 2010

ended 03/31/10 Q1

Prospectuses and Registrations Filter

Securities registration termination

Exempt offering of securities

Registration of successor issuer's securities

Registration of securities – amended

Registration of securities – amended

Ownership Filter

Orbimed Asia GP, LP

Isaly Samuel D, Orbimed Advisors LLC, Orbimed Asia GP, LP, OrbiMed Advisors Ltd

Orbimed Advisors LLC

News Filter

Material Disclosure

Material Definitive Agreement, Termination of Material Definitive Agreement, Change in Directors, Officers or Compensation, Financial Statements or Exhibits

Announces That They Have Obtained the Manufacturing Approval for Entecavir From the China State Food and Drug Administration

Material Definitive Agreement, Unregistered Sales of Equity Securities, Material Modification to Rights of Security Holders, Change in Directors, Officers or Compensation, Amendment to Articles of Incorporation or Bylaws, or Change in Fiscal Year, Financial Statements or Exhibits

Material Definitive Agreement, Unregistered Sales of Equity Securities, Financial Statements or Exhibits

Proxies

No filings in this category.

Other Filter

Confidential treatment order

Notice of effectiveness

Letter from the SEC

Letter from the SEC